PCR fluorescence
-
14 ʻAno o nā pathogens hanu i hui pū ʻia
Hoʻohana ʻia kēia pahu no ka ʻike in vitro qualitative o ka coronavirus novel (SARS-CoV-2), ka maʻi Influenza A (IFV A), ka maʻi Influenza B (IFV B), ka maʻi maʻi hanu hanu (RSV), Adenovirus (Adv), metapneumovirus kanaka (hMPV), rhinovirus (Rhv), ʻano maʻi virus Parainfluenza/IV/IV (PIIV) kanaka. (HBoV), Enterovirus (EV), Coronavirus (CoV), Mycoplasma pneumoniae (MP), Chlamydia pneumoniae (Cpn), a me Streptococcus pneumoniae (SP) nucleic acids i loko o ke kanaka oropharyngeal swab a me nasopharyngeal swab samples.
-
Orientia tsutsugamushi
Hoʻohana ʻia kēia pahu hana no ka ʻike ʻana i ka qualitative o ka nucleic acid o Orientia tsutsugamushi i loko o nā laʻana serum.
-
ʻO ka Mycobacterium Tuberculosis Nucleic Acid a me Rifampicin (RIF), Resistance (INH)
Hoʻohana ʻia kēia pahu no ka ʻike ʻana i ka DNA Mycobacterium tuberculosis in vitro i loko o ka sputum kanaka, ka moʻomeheu paʻa (LJ Medium) a me ka moʻomeheu wai (MGIT Medium), ka wai lavage bronchial, a me nā mutations ma ka ʻāpana codon amino acid 507-533 (81bp, rifampicin resistance determing region) o ka gene rpoB o Mycobacterium tuberculosis rifampicin resistance, a me nā mutations ma nā wahi mutation nui o Mycobacterium tuberculosis isoniazid resistance. Hāʻawi ia i ke kōkua i ka ʻike ʻana i ka maʻi Mycobacterium tuberculosis, a ʻike ia i nā genes pale nui o rifampicin a me isoniazid, e kōkua ana i ka hoʻomaopopo ʻana i ke kūʻē ʻana o ka lāʻau lapaʻau o Mycobacterium tuberculosis i loaʻa i ka maʻi.
-
ʻAno Poliovirus Ⅲ
He kūpono kēia pahu hana no ka ʻike ʻana i ka Poliovirus Type Ⅲ nucleic acid i loko o nā hāpana ʻōpala kanaka ma vitro.
-
ʻAno Poliovirus Ⅰ
He kūpono kēia pahu hana no ka ʻike ʻana i ka poliovirus type I nucleic acid i loko o nā hāpana lepo kanaka ma vitro.
-
ʻAno Poliovirus II
He kūpono kēia pahu hana no ka ʻike ʻana i ka Poliovirus Type Ⅱnucleic acid i loko o nā hāpana ʻōpala kanaka ma vitro.
-
ʻO ka maʻi Enterovirus 71 (EV71)
Ua manaʻo ʻia kēia pahu hana no ka ʻike ʻana i ka enterovirus 71 (EV71) nucleic acid in vitro i loko o nā swabs oropharyngeal a me nā laʻana wai herpes o nā maʻi me ka maʻi lima-wāwae-waha.
-
ʻO Enterovirus Universal
Ua manaʻo ʻia kēia huahana no ka ʻike ʻana i nā enteroviruses in vitro i loko o nā swabs oropharyngeal a me nā hāpana wai herpes. ʻO kēia pahu hana no ke kōkua ʻana i ka ʻike ʻana i ka maʻi lima-wāwae-waha.
-
Pahu ʻike ʻana i ka waikawa nucleic herpes simplex type 1 (Fluorescence PCR)
Hoʻohana ʻia kēia pahu hana no ka ʻike ʻana i ka maʻi Herpes Simplex Type 1 (HSV1).
-
ʻO Chlamydia Trachomatis, Neisseria Gonorrhoeae a me Trichomonas vaginalis Nucleic Acid Detection Kit (Fluorescence PCR)
Ua manaʻo ʻia ka pahu hana no ka ʻike ʻana i ka qualitative in vitro o Chlamydia trachomatis (CT), Neisseria gonorrhoeae (NG)a meʻO ka Trichomonal vaginitis (TV) i loko o ka swab urethral kāne, ka swab cervical wahine, a me nā laʻana swab vaginal wahine, a hāʻawi i ke kōkua i ka ʻike ʻana a me ka mālama ʻana i nā maʻi me nā maʻi genitourinary tract.
-
Pahu ʻIke Waikawa Nucleic Trichomonas Vaginalis (Fluorescence PCR)
Hoʻohana ʻia kēia pahu hana no ka ʻike ʻana i ka qualitative o ka Trichomonas vaginalis nucleic acid i loko o nā hāpana huna o ke ala urogenital kanaka.
-
Ua hui pū ʻia nā pathogens hanu
Hoʻohana ʻia kēia pahu hana no ka ʻike qualitative o nā pathogens hanu i loko o ka nucleic acid i unuhi ʻia mai nā hāpana swab oropharyngeal kanaka.
Hoʻohana ʻia kēia kumu hoʻohālike no ka ʻike qualitative o 2019-nCoV, ka maʻi influenza A, ka maʻi influenza B a me nā nucleic acids o ka respiratory syncytial virus i loko o nā hāpana swab oropharyngeal kanaka.
